Xspray Pharma AB (publ)
SSE:XSPRAY.ST
44 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 166.303 | 120.166 | 271.881 | 325.598 | 209.872 | 221.266 | 115.512 | 28.803 | 11.85 |
| Short Term Investments
| 0 | -2.999 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 166.303 | 120.166 | 271.881 | 325.598 | 209.872 | 221.266 | 115.512 | 28.803 | 11.85 |
| Net Receivables
| 4.165 | 3.513 | 3.986 | 3.316 | 5.709 | 1.675 | 0.023 | 0.019 | 0.188 |
| Inventory
| 43.781 | 8.552 | 6.199 | 0 | 0 | -1.675 | -0.023 | 2.437 | -0.188 |
| Other Current Assets
| 3.566 | -0.002 | -0.001 | 2.101 | 0.545 | 5.595 | 1.83 | 0.001 | 1.445 |
| Total Current Assets
| 217.815 | 132.229 | 282.065 | 331.015 | 216.126 | 226.861 | 117.342 | 31.26 | 13.295 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 107.651 | 64.604 | 44.601 | 42.669 | 43.03 | 13.73 | 2.461 | 0.48 | 0.483 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 436.78 | 385.597 | 296.236 | 231.618 | 141.515 | 71.893 | 41.609 | 20.12 | 1.173 |
| Goodwill and Intangible Assets
| 436.78 | 385.597 | 296.236 | 231.618 | 141.515 | 71.893 | 41.609 | 20.12 | 1.173 |
| Long Term Investments
| 3.017 | 3 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Tax Assets
| -0.001 | -3 | -0.001 | -0.001 | 0 | -0.001 | -0.001 | -0.001 | -0.001 |
| Other Non-Current Assets
| 0.001 | 2.999 | 0.001 | 0.001 | -0.001 | 0.001 | 0.001 | 0.002 | 0.001 |
| Total Non-Current Assets
| 547.448 | 453.2 | 340.838 | 274.288 | 184.545 | 85.624 | 44.071 | 20.602 | 1.657 |
| Total Assets
| 765.263 | 585.43 | 622.903 | 605.303 | 400.672 | 312.485 | 161.413 | 51.862 | 14.951 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 12.472 | 14.786 | 16.865 | 8.438 | 11.876 | 7.78 | 2.89 | 4.343 | 0.821 |
| Short Term Debt
| 4.861 | 1.566 | 2.048 | 1.958 | 0.876 | 0 | 0 | 0 | 0 |
| Tax Payables
| 2.375 | 2.058 | 1.576 | 1.268 | 0.922 | 0.323 | 0.202 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 10.4 | 8.628 | 9.007 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 22.57 | 12.499 | 0.653 | 0.794 | 0.744 | 2.989 | 2.863 | 1.045 | 1.867 |
| Total Current Liabilities
| 39.903 | 28.851 | 29.966 | 19.818 | 22.503 | 10.769 | 5.754 | 5.388 | 2.688 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 31.947 | 0.56 | 1.185 | 2.898 | 4.454 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 31.947 | 0.56 | 1.185 | 2.898 | 4.454 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 71.85 | 29.411 | 31.151 | 22.716 | 26.957 | 10.769 | 5.754 | 5.388 | 2.688 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 51.327 | 0 | 0 | 0 |
| Common Stock
| 31.254 | 22.68 | 20.68 | 18.893 | 16.752 | 15.076 | 12.356 | 6.356 | 3.316 |
| Retained Earnings
| -554.725 | -375.057 | -243.387 | -146.689 | -94.279 | -51.327 | 101.137 | 19.816 | 7.971 |
| Accumulated Other Comprehensive Income/Loss
| 0.792 | 0.976 | 0.976 | 0.976 | 0.976 | -51.327 | 42.166 | 0 | 0 |
| Other Total Stockholders Equity
| 1,216.092 | 907.42 | 813.483 | 709.407 | 450.266 | 337.967 | 0 | 20.302 | 0.976 |
| Total Shareholders Equity
| 693.413 | 556.019 | 591.752 | 582.587 | 373.715 | 301.716 | 155.66 | 46.474 | 12.263 |
| Total Equity
| 693.413 | 556.019 | 591.752 | 582.587 | 373.715 | 301.716 | 155.66 | 46.474 | 12.263 |
| Total Liabilities & Shareholders Equity
| 765.263 | 585.43 | 622.903 | 605.303 | 400.672 | 312.485 | 161.413 | 51.862 | 14.951 |